Home › Funds › CaixaBank, S.A. › EW

CaixaBank, S.A. position in EW

EDWARDS LIFESCIENCES · Health Care

CaixaBank, S.A. reported holding 1,170,938 shares of EW (EDWARDS LIFESCIENCES) in its Q3 2026 13F filing — a position valued at US$101.1M, representing 0.45% of its reported portfolio and ranking #50 among its reported holdings. CaixaBank, S.A. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.17M sh
Reported value held$101.08M
Portfolio Weight0.45%
First reportedQ3 2023
Last changeAdd
Updated2026-11-21

Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR

How CaixaBank, S.A.'s EW position evolved

CaixaBank, S.A. first disclosed a stake in EW in Q3 2023 at 458,431 shares (US$31.8M). The position peaked in Q4 2025 at 1,432,302 shares, worth US$122.1M. Across 13 filings, CaixaBank, S.A. increased the stake 7 time(s), trimmed it 5 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,170,938 shares valued at US$101.1M — an increase of 229,461 shares quarter over quarter.. Notable position changes include a 135% increase in Q4 2024 (shares fell 2% over the following quarter), a 38% increase in Q1 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 458.43K $31.76M New
Q4 2023 436.21K $33.26M Reduce
Q1 2024 374.44K $35.79M Reduce
Q2 2024 426.62K $39.41M Add
Q3 2024 342.74K $22.62M Reduce
Q4 2024 804.77K $59.58M Add
Q1 2025 1.11M $80.47M Add
Q2 2025 1.34M $105.18M Add
Q3 2025 1.36M $105.43M Add
Q4 2025 1.43M $122.10M Add
Q1 2026 1.12M $90.03M Reduce
Q2 2026 941.48K $85.17M Reduce
Q3 2026 1.17M $101.08M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES) is a Health Care company. 28 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), Ninety One UK Ltd (US$1.03B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$923.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has CaixaBank, S.A. held EW?

CaixaBank, S.A. has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is CaixaBank, S.A.'s current position in EW?

As of Q3 2026, CaixaBank, S.A. holds 1.17M shares of EW (EDWARDS LIFESCIENCES), valued at $101.08M, representing 0.45% of its reported portfolio and ranking #50.

Has CaixaBank, S.A. been buying or selling EW?

In the latest 13F filing (Q3 2026), CaixaBank, S.A. increased its position in EW. The position peaked in Q4 2025 at 1.43M shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, Ninety One UK Ltd, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.